de Boer A - Search Results

1

Selection of oncology medicines in low- and middle-income countries.

Bazargani YT, de Boer A, Schellens JH, Leufkens HG, Mantel-Teeuwisse AK. Bazargani YT, et al. Among authors: de boer a. Ann Oncol. 2014 Jan;25(1):270-6. doi: 10.1093/annonc/mdt514. Ann Oncol. 2014. PMID: 24356638 Free article.

2

Essential medicines for COPD and asthma in low and middle-income countries.

Bazargani YT, de Boer A, Leufkens HG, Mantel-Teeuwisse AK. Bazargani YT, et al. Among authors: de boer a. Thorax. 2014 Dec;69(12):1149-51. doi: 10.1136/thoraxjnl-2014-205249. Epub 2014 Mar 3. Thorax. 2014. PMID: 24590803

3

Essential medicines for breast cancer in low and middle income countries.

Bazargani YT, de Boer A, Schellens JH, Leufkens HG, Mantel-Teeuwisse AK. Bazargani YT, et al. Among authors: de boer a. BMC Cancer. 2015 Aug 18;15:591. doi: 10.1186/s12885-015-1583-4. BMC Cancer. 2015. PMID: 26283654 Free PMC article.

4

Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries.

Kleijnen S, Lipska I, Leonardo Alves T, Meijboom K, Elsada A, Vervölgyi V, d'Andon A, Timoney A, Leufkens HG, De Boer A, Goettsch WG. Kleijnen S, et al. Among authors: de boer a. Ann Oncol. 2016 Sep;27(9):1768-75. doi: 10.1093/annonc/mdw233. Epub 2016 Jun 20. Ann Oncol. 2016. PMID: 27329251 Free article.

5

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.

Bazargani YT, Ugurlu M, de Boer A, Leufkens HGM, Mantel-Teeuwisse AK. Bazargani YT, et al. Among authors: de boer a. BMC Cardiovasc Disord. 2018 Jun 25;18(1):126. doi: 10.1186/s12872-018-0858-5. BMC Cardiovasc Disord. 2018. PMID: 29940880 Free PMC article.

6

Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study.

Lalmohamed A, Bazelier MT, Van Staa TP, Uitdehaag BM, Leufkens HG, De Boer A, De Vries F. Lalmohamed A, et al. Among authors: de vries f, de boer a. Eur J Neurol. 2012 Jul;19(7):1007-14. doi: 10.1111/j.1468-1331.2012.03668.x. Epub 2012 Feb 21. Eur J Neurol. 2012. PMID: 22353360

7

Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement.

Lalmohamed A, Vestergaard P, Jansen PA, Grove EL, de Boer A, Leufkens HG, van Staa TP, de Vries F. Lalmohamed A, et al. Among authors: de vries f, de boer a. J Thromb Haemost. 2013 Apr;11(4):642-50. doi: 10.1111/jth.12158. J Thromb Haemost. 2013. PMID: 23387806 Free article.

8

Risk of fracture in patients with muscular dystrophies.

Pouwels S, de Boer A, Leufkens HG, Weber WE, Cooper C, van Onzenoort HA, de Vries F. Pouwels S, et al. Among authors: de vries f, de boer a. Osteoporos Int. 2014 Feb;25(2):509-18. doi: 10.1007/s00198-013-2442-2. Epub 2013 Aug 15. Osteoporos Int. 2014. PMID: 23948807

9

Risk of fracture in patients with Guillain-Barré syndrome.

Pouwels S, de Boer A, Leufkens HG, Weber WE, Cooper C, van Staa TP, de Vries F. Pouwels S, et al. Among authors: de vries f, de boer a. Osteoporos Int. 2014 Jul;25(7):1845-51. doi: 10.1007/s00198-014-2705-6. Epub 2014 Apr 24. Osteoporos Int. 2014. PMID: 24760245

10

Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands.

Fazeli Farsani S, Souverein PC, Overbeek JA, van der Vorst MM, Knibbe CA, Herings RM, de Boer A, Mantel-Teeuwisse AK. Fazeli Farsani S, et al. Among authors: de boer a. Br J Clin Pharmacol. 2015 Aug;80(2):294-303. doi: 10.1111/bcp.12608. Epub 2015 May 20. Br J Clin Pharmacol. 2015. PMID: 25683632 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,398 results

Search Page

Filters